Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 3"
publishDate:"[2020 TO 2020]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2020%5D%22&lookfor=%22coronavirus+infections%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2020%5D%22&lookfor=%22coronavirus+infections%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2020%5D%22&lookfor=%22coronavirus+infections%22&type=Subject
PubPharm (77)
1
Baricitinib in Patients with COVID-19 Infection : A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients with COVID-19 Infection - COV-BARRIER
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
2
Baricitinib in Patients with COVID-19 Infection : A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients with COVID-19 Infection - COV-BARRIER
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
3
Novel Regimens in COVID-19 Treatment : Nitazoxanide in Treatment of COVID-19
enthalten in:
ClinicalTrials.gov
| 2020
Wird geladen...
4
This study will test a drug named remdesivir (GS-5734™) to evaluate the safety and effectiveness of the drug in treating patients with severe coronavirus disease 2019 (COVID-19). : A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19 - .
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
5
This study will test a drug named remdesivir (GS-5734™) to evaluate the safety and effectiveness of the drug in treating patients with moderate coronavirus disease 2019 (COVID-19) compared to standard of care treatment. : A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment - .
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
6
This study will test a drug named remdesivir (GS-5734™) to evaluate the safety and effectiveness of the drug in treating patients with severe coronavirus disease 2019 (COVID-19). : A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19 - .
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
7
This study will test a drug named remdesivir (GS-5734™) to evaluate the safety and effectiveness of the drug in treating patients with moderate coronavirus disease 2019 (COVID-19) compared to standard of care treatment. : A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment - .
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
8
A Study of a Candidate COVID-19 Vaccine (COV003) : A Randomized, Controlled, Phase III Study to Determine the Safety, Efficacy, and Immunogenicity of the Non-Replicating ChAdOx1 nCoV-19 Vaccine
enthalten in:
ClinicalTrials.gov
| 2020
Wird geladen...
9
A trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients hospitalised with moderate COVID-19 : A randomised, double-blind, placebo-controlled, Phase III trial to determine the efficacy and safety of inhaled SNG001 for the treatment of patients hospitalised due to moderate COVID-19 - Phase III trial of inhaled anti-viral (SNG001) for SARS-CoV-2
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
10
Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have not been exposed to COVID-19 infection : A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Pre-exposure Prophylaxis of COVID-19 - Phase 3 Double-blind study of AZD7442 or Placebo for Pre-exposure Prophylaxis of COVID-19 in Adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
1
2
3
4
5
6
7
8
Nächster »
[8]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 3
Filter aufheben
Erscheinungsjahr: 2020-2020
Medienart
77
Aufsätze
77
E-Artikel
77
E-Ressourcen
Zeitschriftentitel
56
WHO International Clinical Trials Registry Plat...
21
ClinicalTrials.gov
Thema
77
610
Phase: Phase 3
77
Study Type: Interventional
33
Recruitment Status: Not yet recruiting
26
Recruitment Status: Authorised-recruitment may ...
21
Coronavirus Infections
16
Medical Condition: Coronavirus disease 2019 (CO...
10
Medical Condition: Coronavirus disease 2019 (CO...
9
Recruitment Status: Recruiting
6
Medical Condition: COVID-19 MedDRA version: 23....
3
Medical Condition: Coronavirus Disease (COVID-19)
3
Recruitment Status: Completed
2
Communicable Diseases
2
Infection
2
Inflammation
2
Medical Condition: COVID-19 (Coronavirus RNA) M...
2
Medical Condition: COVID-19 (SARS-CoV-2) infect...
2
Medical Condition: COVID-19 Infection MedDRA ve...
2
Medical Condition: COVID-19 MedDRA version: 23....
2
Medical Condition: COVID-19 MedDRA version: 23....
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2020-2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
77
Englisch
Haven't found what you're looking for?
Wird geladen...